Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Long-Term Debt Repayments (2021 - 2025)

Biodesix (BDSX) has disclosed Long-Term Debt Repayments for 5 consecutive years, with $5000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Debt Repayments fell 61.54% year-over-year to $5000.0, compared with a TTM value of $21000.0 through Dec 2025, down 58.82%, and an annual FY2025 reading of $21000.0, down 58.82% over the prior year.
  • Long-Term Debt Repayments was $5000.0 for Q4 2025 at Biodesix, up from $4000.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $25.4 million in Q1 2021 and bottomed at $3000.0 in Q2 2021.
  • Average Long-Term Debt Repayments over 5 years is $3.7 million, with a median of $12000.0 recorded in 2023.
  • Peak annual rise in Long-Term Debt Repayments hit 100366.67% in 2022, while the deepest fall reached 99.96% in 2022.
  • Year by year, Long-Term Debt Repayments stood at $20.0 million in 2021, then increased by 17.81% to $23.6 million in 2022, then tumbled by 99.94% to $13000.0 in 2023, then changed by 0.0% to $13000.0 in 2024, then crashed by 61.54% to $5000.0 in 2025.
  • Business Quant data shows Long-Term Debt Repayments for BDSX at $5000.0 in Q4 2025, $4000.0 in Q3 2025, and $5000.0 in Q2 2025.